Related Experiment Video
Updated: Feb 15, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
Linking oncogenic pathways with therapeutic opportunities
Andrea H Bild1, Anil Potti, Joseph R Nevins
1Duke Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, North Carolina 27710, USA.
Abstract:
The accumulation of multiple mutations and alterations in the cancer genome underlies the complexity of cancer phenotypes. A consequence of these alterations is the deregulation of various cell-signalling pathways that control cell function. Molecular-profiling studies, particularly DNA microarray analyses, have the potential to describe this complexity. These studies also provide an opportunity to link pathway deregulation with potential therapeutic strategies. This approach, when coupled with other methods for identifying pathway activation, provides an opportunity to both match individual patients with the most appropriate therapeutic strategy and identify potential options for combination therapy.
Insights
Cancer genome alterations cause complex phenotypes and pathway deregulation. Molecular profiling links these changes to targeted therapies and combination treatments for personalized cancer care.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Cancer arises from accumulated mutations and genomic alterations, leading to complex phenotypes.
- These genetic changes frequently result in the deregulation of critical cell-signalling pathways that govern cellular functions.
- Understanding pathway deregulation is key to deciphering cancer's complexity.
Approach:
- Utilizing molecular-profiling techniques, such as DNA microarray analyses, to comprehensively map genomic complexity.
- Integrating pathway activation data with molecular profiles to identify therapeutic targets.
- Employing a multi-modal approach to link molecular findings with clinical applications.
Key Points:
- Molecular profiling reveals intricate cancer genome alterations and their impact on cell signalling.
- Deregulation of cell-signalling pathways is a direct consequence of cancer-associated genetic changes.
- DNA microarray analysis offers a powerful method for characterizing cancer's molecular landscape.
Conclusions:
- Linking pathway deregulation to molecular profiles enables personalized therapeutic strategies.
- This integrated approach facilitates the matching of patients with optimal treatments.
- It also identifies promising avenues for developing effective combination therapies in cancer treatment.
Related Concept Videos
X-linked Traits
Sex-linked Disorders
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

